Efficacy And Safety Of A 52 Week Open Label Phase 2b Extension Trial With Monthly Dosing Of An Anti-Pcsk9 Small Binding Protein

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2020)

引用 2|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要